USPTO Trademark Application: PATIENTS FIRST
Summary
The USPTO has received an intent-to-use trademark application for "PATIENTS FIRST" filed on March 22, 2026. The application covers wholesale distribution of pharmaceutical products and medical devices, as well as providing health information and educational services related to medication adherence and patient safety.
What changed
The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application (TM99492717) for the mark "PATIENTS FIRST." The application, filed on March 22, 2026, specifies wholesale distribution services for prescription and non-prescription pharmaceuticals, medical devices, and other FDA-regulated products. It also includes services related to health information provision, educational programs on pharmaceutical wholesaling and patient safety, and quality control for pharmaceutical wholesale distribution.
This filing indicates a potential new market entrant or expansion of services in the pharmaceutical and medical device wholesale sector. Compliance officers should note the scope of services claimed, particularly those related to FDA-regulated products and health information, as these may intersect with existing regulatory obligations concerning drug distribution, patient safety, and data privacy. No immediate compliance actions are required based on this trademark filing, but it signals potential future business activities within the regulated healthcare industry.
Source document (simplified)
← USPTO Trademark Applications
PATIENTS FIRST
Intent to Use TM99492717 Kind: intenttouse Mar 22, 2026
Abstract
Wholesale distribution in the nature of wholesale distributorships featuring prescription and non-prescription pharmaceutical products, medical devices, and other FDA regulated products; wholesale ordering services in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices; wholesale services by direct solicitation by sales agents in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices; on-line wholesale store services featuring prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices.; Providing health information to pharmacies and healthcare providers in the field of medication adherence, safe use of pharmaceuticals, and patient safety; Providing educational services, namely, conducting information sessions and training programs in the field of pharmaceutical wholesaling and distribution best practices, patient safety, and medication adherence; FDA-regulated pharmaceutical products including brand medicine, generic medicine, biologics and biosimilars, orphan drugs, over-the-counter drugs, controlled substances, medical devices, vitamins, and supplements for the treatment of cardiovascular diseases; neurological disorders; psychiatric and psychological conditions; infectious diseases including viral, bacterial, and fungal infections; HIV and hepatitis; oncological diseases and malignancies; dermatological conditions; pulmonary and respiratory disorders; nephrological diseases; gastrointestinal and hepatic conditions; hematologic disorders; reproductive and fertility-related conditions; immunological and allergic conditions; endocrine and metabolic disorders including diabetes; musculoskeletal and orthopedic conditions; ophthalmologic disorders; transplant-related conditions and post-operative complications; as well as for the management of pain and other chronic or acute medical conditions.; Quality control for recipients in the field of pharmaceutical wholesale distribution
Filing Date
2025-11-12
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Trademarks - Medical Services (Class 044) publishes new changes.